Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update

Title: Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update
Authors: Valzania C; Paccagnella A; Spadotto A; Ruotolo I; Bonfiglioli R; Fallani F; Fanti S; Galié N.
Contributors: Valzania C, Paccagnella A, Spadotto A, Ruotolo I, Bonfiglioli R, Fallani F, Fanti S, Galié N.
Publication Year: 2023
Collection: IRIS Università degli Studi di Bologna (CRIS - Current Research Information System)
Subject Terms: Test; diseases/processe; outcomes
Description: Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer disease survivors. Several imaging surveillance techniques have been proposed for early diagnosis of cancer therapy-induced cardiac dysfunction. Our aim was to provide an update of radionuclide angiography applications in this field. Radionuclide angiography is widely used to assess left ventricular ejection fraction (LVEF) throughout cancer treatment, especially in patients with limited acoustic window. Additional prognostic data may be provided by phase analysis and diastolic function evaluation. Low LVEF and high approximate entropy at baseline seem to be predictors for cancer therapy-induced cardiac dysfunction. A decrease in peak filling rate and/or an increase in time to peak filling rate may be observed in patients undergoing anthracycline and/or trastuzumab administration. Diastolic function impairment may precede or not LVEF decrease. In conclusion, recent studies have provided novel insights into the possible role of radionuclide angiography in the early detection of cancer therapy cardiotoxicity. While interpreting the results of a radionuclide angiography examination, an integrated approach combining the evaluation of LVEF, LV diastolic function, and phase analysis may be useful to improve risk stratification of cancer patients treated with cardiotoxic agents.
Document Type: article in journal/newspaper
File Description: STAMPA
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/36855007; info:eu-repo/semantics/altIdentifier/wos/WOS:000941300200003; volume:30; firstpage:2014; lastpage:2111; numberofpages:98; journal:JOURNAL OF NUCLEAR CARDIOLOGY; https://hdl.handle.net/11585/958163
DOI: 10.1007/s12350-023-03202-w
Availability: https://hdl.handle.net/11585/958163; https://doi.org/10.1007/s12350-023-03202-w
Accession Number: edsbas.59CDC6F0
Database: BASE